Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 22;4(18):4574-4583.
doi: 10.1182/bloodadvances.2020002947.

Systems-based hematology: highlighting successes and next steps

Affiliations
Review

Systems-based hematology: highlighting successes and next steps

Jori E May et al. Blood Adv. .

Abstract

Systems-based hematology is dedicated to improving care delivery for patients with blood disorders. First defined by the American Society of Hematology in 2015, the idea of a systems-based hematologist arose from evolving pressures in the health care system and increasing recognition of opportunities to optimize the quality and cost effectiveness of hematologic care. In this review, we begin with a proposed framework to formalize the discussion of the range of initiatives within systems-based hematology. Classification by 2 criteria, project scope and method of intervention, facilitates comparison between initiatives and supports dialogue for future efforts. Next, we present published examples of successful systems-based initiatives in the field of hematology, including efforts to improve stewardship in the diagnosis and management of complex hematologic disorders (eg, heparin-induced thrombocytopenia and thrombophilias), the development of programs to promote appropriate use of hematologic therapies (eg, blood products, inferior vena cava filters, and anticoagulation), changes in care delivery infrastructure to improve access to hematologic expertise (eg, electronic consultation and disorder-specific care pathways), and others. The range of projects illustrates the broad potential for interventions and highlights different metrics used to quantify improvements in care delivery. We conclude with a discussion about future directions for the field of systems-based hematology, including extension to malignant disorders and the need to define, expand, and support career pathways.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: S.F. has served as medical director for HemeOnc Call, LLC, which has a section on telemedicine. A.R. has served on advisory boards for Alexion, Baxter, Bayer, and Kedrion Biopharma Octapharma Plasma, and her institution has received research support on her behalf from Alnylam (Sanofi Genzyme), Baxalta (Shire), Biomarin, Dimensions Therapeutics, Genetech, Janssen Pharmaceuticals, and Roche. M.S.Z. has served as a member of the American Board of Internal Medicine’s Hematology Board and provided consultancy for Novartis and legal case review. The remaining authors declare no competing financial interests.

Figures

Figure 1.
Figure 1.
Classification of systems-based initiatives. Classification by scope (A) and method of intervention (B).

References

    1. Wallace PJ, Connell NT, Abkowitz JL. The role of hematologists in a changing United States health care system. Blood. 2015;125(16):2467-2470. - PMC - PubMed
    1. Lewin Group, Inc. Systems-based clinical hematologist project: business case portfolio. https://www.hematology.org/education/clinicians/clinical-priorities/syst.... Accessed 1 January 2020.
    1. Grimshaw JM, Shirran L, Thomas R, et al. . Changing provider behavior: an overview of systematic reviews of interventions. Med Care. 2001;39(8suppl 2):II2-II45. - PubMed
    1. Cuker A, Arepally GM, Chong BH, et al. . American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv. 2018;2(22):3360-3392. - PMC - PubMed
    1. Chaturvedi S, Kohli R, McCrae K. Over-testing for heparin induced thrombocytopenia in hospitalized patients. J Thromb Thrombolysis. 2015;40(1):12-16. - PubMed

Publication types